Benefit of treatment with pirfenidone (PFD) persists over time in patients with idiopathic pulmonary fibrosis (IPF) with limited lung function impairment

被引：4
|
作者：
Noble, Paul
Albera, Carlo
Kirchgaessler, Klaus-Uwe
Gilberg, Frank
Petzinger, Ute
Costabel, Ulrich
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2016年 / 48卷
关键词：
Interstitial lung disease;
D O I：
10.1183/13993003.congress-2016.OA1809
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
OA1809
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Pirfenidone (PFD) effect on morbidity and mortality in patients with idiopathic pulmonary fibrosis (IPF)
    Noble, Paul W.
    Albera, Carlo
    Bradford, Williamson Z.
    Costabel, Ulrich
    du Bois, Roland M.
    Fishman, Robert S.
    Glaspole, Ian
    Glassberg, Marilyn K.
    Lancaster, Lisa
    Lederer, David
    Leff, Jonathan A.
    Nathan, Steven D.
    Pereira, Carlos A.
    Swigris, Jeffrey J.
    Valeyre, Dominique
    King, Talmadge E.
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [2] The long-term safety of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF)
    Valeyre, Dominique
    Albera, Carlo
    Bradford, Williamson
    Costabel, Ulrich
    King, Talmadge
    Noble, Paul
    Sahn, Steven
    du Bois, Roland
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [3] Analysis of Patients With Idiopathic Pulmonary Fibrosis (IPF) With More Severe Lung Function Impairment Treated With Pirfenidone in Recap
    Costabel, Ulrich
    Albera, Carlo
    Kirchgaessler, Klaus-Uwe
    Gilberg, Frank
    Petzinger, Ute
    Ruhrlandklinik, Paul Noble
    CHEST, 2016, 150 (04) : 537A - 537A
  • [4] Analysis of lung function and survival in RECAP: An open-label extension study of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF)
    Costabel, Ulrich
    Albera, Carlo
    Bradford, Williamson
    Hormel, Phil
    King, Talmadge
    Noble, Paul
    Sahn, Steven
    Valeyre, Dominique
    du Bois, Roland
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [5] PIRFENIDONE IS EFFICACIOUS IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) WITH MORE PRESERVED LUNG FUNCTION
    Noble, P. W.
    Bradford, W. Z.
    Costabel, U.
    Glaspole, I.
    Glassberg, M. K.
    Gorina, E.
    Kardatzke, D.
    Lancaster, L.
    Lederer, D. J.
    Nathan, S. D.
    Pereira, C.
    Spirig, D.
    Swigris, J. J.
    Valeyre, D.
    Albera, C.
    THORAX, 2015, 70 : A81 - A81
  • [6] EFFECT OF PIRFENIDONE ON EXERCISE CAPACITY AND DYSPNEA IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) AND MORE ADVANCED LUNG FUNCTION IMPAIRMENT
    Nathan, Steven
    Bradley, Sarah
    Costabel, Ulrich
    Albera, Carlo
    Behr, Juergen
    Wuyts, Wim
    Kirchgaessler, Klaus-Uwe
    Stauffer, John
    Morgenthien, Elizabeth
    Yang, Ming
    Limb, Susan
    Noble, Paul
    CHEST, 2018, 154 (04) : 432A - 433A
  • [7] Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairment
    Nathan, Steven D.
    Costabel, Ulrich
    Albera, Carlo
    Behr, Juergen
    Wuyts, Wim A.
    Kirchgaessler, Klaus-Uwe
    Stauffer, John L.
    Morgenthien, Elizabeth
    Chou, Willis
    Limb, Susan L.
    Noble, Paul W.
    RESPIRATORY MEDICINE, 2019, 153 : 44 - 51
  • [8] The effect of pirfenidone on impaired lung function in patients with idiopathic pulmonary fibrosis (IPF) from Czech IPF registry
    Zurkova, Monika
    Kolek, Vitezslav
    Lostakova, Vladimira
    Kriegova, Eva
    Sterclova, Martina
    Bartos, Vladimir
    Doubkova, Martina
    Binkova, Ilona
    Svoboda, Michal
    Strenkova, Jana
    Plackova, Martina
    Lacina, Ladislav
    Rihak, Vladimir
    Petrik, Frantisek
    Lisa, Pavlina
    Bittenglova, Radka
    Tyl, Richard
    Ondrejka, Gustav
    Suldova, Hana
    Lnenicka, Jaroslav
    Psikalova, Jana
    Snizek, Tomas
    Homolka, Jiri
    Kralova, Renata
    Kervitzer, Jan
    Vasakova, Martina
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [9] Fatigue in patients with idiopathic pulmonary fibrosis (IPF) from the pooled pirfenidone (PFD) Phase III trials
    Costabel, Ulrich
    Albera, Carlo
    Wijsenbeek, Marlies S.
    de Andrade, Joao A.
    Mason, Wendi R.
    Nathan, Steven D.
    Zibrak, Joseph D.
    Padilla, Maria L.
    Gilberg, Frank
    Petzinger, Ute
    Kirchgaessler, Klaus-Uwe
    Lancaster, Lisa H.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [10] Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF)
    Balestro, Elisabetta
    Turato, Graziella
    Biondini, Davide
    Pavanello, Sofia
    Fraccaro, Alessia
    Rigobello, Chiara
    Bazzan, Erica
    Campisi, Manuela
    Baraldo, Simonetta
    Cosio, Manuel
    Saetta, Marina
    Spagnolo, Paolo
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
12345